voriconazole has been researched along with betadex in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (12.50) | 29.6817 |
2010's | 17 (70.83) | 24.3611 |
2020's | 4 (16.67) | 2.80 |
Authors | Studies |
---|---|
Burhenne, J; von Mach, MA; Weilemann, LS | 1 |
Abel, S; Allan, R; Gandelman, K; Tomaszewski, K; Webb, DJ; Wood, ND | 1 |
Bosselmann, S; McConville, JT; Nelson, NA; Peters, JI; Son, YJ; Tolman, JA; Wiederhold, NP; Williams, RO | 1 |
Damle, B; Luke, DR; Schlamm, HT; Tomaszewski, K | 1 |
Bommer, J; Burhenne, J; Czock, D; Haefeli, WE; Hafner, V; Machleidt, C; Mikus, G; Riedel, KD; Weinreich, T | 1 |
Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T | 1 |
Damle, B; Luke, DR; Tomaszewski, KE; Wood, ND | 1 |
Kashyap, H; Malhotra, S; Pawar, P; Sindhu, R | 1 |
Sebestyén, Z; Szabó, B; Szepesi, K | 1 |
Graovac, A; Ibric, S; Kyriakos, K; Miletic, T | 1 |
Kashyap, H; Pahuja, P; Pawar, P | 1 |
Crommen, J; Farcas, E; Fillet, M; Moldovan, R; Roland, I; Servais, AC | 1 |
Aquilante, CL; Fish, DN; Kiser, TH; MacLaren, R; Rower, JE; Teitelbaum, I; Wempe, MF | 1 |
De Waele, E; Hendrickx, I; Honore, PM; Jacobs, R; Spapen, HD; Van Gorp, V | 1 |
Bikiaris, DN; Er, S; Giannakopoulou, S; Karavas, E; Mone, M; Pavlidou, E; Siafaka, PI; Üstündağ Okur, N | 1 |
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Han, S; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Park, C; Park, SH; Yim, DS; Yoo, JH | 1 |
Cai, Z; Lv, Y; Sun, X; Yu, L; Yu, Z | 1 |
Konuma, T; Kuroda, S; Takahashi, S; Tojo, A; Yasu, T | 1 |
Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
Andersen, SK; Csontos, I; Démuth, B; Farkas, A; Hirsch, E; Marosi, G; Nagy, B; Nagy, ZK; Szabó, E; Vass, P; Verreck, G; Vigh, T | 1 |
Li, Y; Liu, H; Pan, H; Wu, H; Zhu, C | 1 |
Groll, A; Tragiannidis, A | 1 |
Wang, L; Zhang, Z | 1 |
Aykaç, K; Başaran, E; Büyükköroğlu, G; Demirel, M; Tunali, Y; Yenilmez, E | 1 |
2 review(s) available for voriconazole and betadex
Article | Year |
---|---|
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).
Topics: Animals; Antifungal Agents; beta-Cyclodextrins; Dogs; Excipients; Humans; Pyrimidines; Rats; Triazoles; Voriconazole | 2010 |
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole | 2013 |
2 trial(s) available for voriconazole and betadex
Article | Year |
---|---|
Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Creatinine; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Renal Insufficiency; Severity of Illness Index; Solubility; Triazoles; Voriconazole | 2008 |
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.
Topics: Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Cross-Over Studies; Female; Half-Life; Hemodiafiltration; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Renal Dialysis; Solvents; Triazoles; Voriconazole | 2010 |
20 other study(ies) available for voriconazole and betadex
Article | Year |
---|---|
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
Topics: Aged; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Solvents; Triazoles; Voriconazole | 2006 |
Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.
Topics: Aerosols; Animals; Area Under Curve; beta-Cyclodextrins; Chemistry, Pharmaceutical; Drug Delivery Systems; Lipopeptides; Lung; Male; Mice; Particle Size; Pharmaceutical Solutions; Plasma; Pyrimidines; Solutions; Triazoles; Voriconazole | 2009 |
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole | 2010 |
Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis.
Topics: Adult; Antifungal Agents; beta-Cyclodextrins; Case-Control Studies; Excipients; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Prognosis; Pyrimidines; Renal Dialysis; Tissue Distribution; Triazoles; Voriconazole | 2012 |
Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adhesiveness; Animals; Antifungal Agents; Aspergillus fumigatus; beta-Cyclodextrins; Candida albicans; Cornea; Drug Delivery Systems; Drug Stability; Eye; Gels; Goats; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Microbial Sensitivity Tests; Permeability; Pyrimidines; Rheology; Temperature; Triazoles; Viscosity; Voriconazole | 2013 |
Spray-dried voriconazole-cyclodextrin complexes: solubility, dissolution rate and chemical stability.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Carbohydrate Conformation; Drug Stability; Molecular Docking Simulation; Pyrimidines; Solubility; Temperature; Triazoles; Voriconazole | 2013 |
Design and evaluation of HP-β-CD based voriconazole formulations for ocular drug delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antifungal Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Cornea; Drug Delivery Systems; Goats; Hydrogen-Ion Concentration; Solubility; Surface Tension; Viscosity; Voriconazole | 2014 |
Development and validation of a liquid chromatographic method for the stability study of a pharmaceutical formulation containing voriconazole using cellulose tris(4-chloro-3-methylphenylcarbamate) as chiral selector and polar organic mobile phases.
Topics: beta-Cyclodextrins; Cellulose; Chromatography, Liquid; Phenylcarbamates; Stereoisomerism; Voriconazole | 2014 |
Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
Topics: Adult; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Replacement Therapy; Therapeutics; Voriconazole | 2015 |
Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
Topics: Antifungal Agents; beta-Cyclodextrins; Humans; Kidney Failure, Chronic; Male; Renal Replacement Therapy; Therapeutics; Voriconazole | 2015 |
Two Different Approaches for Oral Administration of Voriconazole Loaded Formulations: Electrospun Fibers versus β-Cyclodextrin Complexes.
Topics: Administration, Oral; Antifungal Agents; beta-Cyclodextrins; Candida; Drug Carriers; Drug Liberation; Nanofibers; Polyesters; Voriconazole | 2016 |
Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
Topics: Administration, Intravenous; Adolescent; Adult; Antifungal Agents; Aspergillosis; beta-Cyclodextrins; Creatinine; Cytochrome P-450 CYP2C19; Drug Compounding; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Voriconazole; Young Adult | 2016 |
Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-β-Cyclodextrin Nanofibers for Ophthalmic Delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antifungal Agents; Area Under Curve; beta-Cyclodextrins; Calorimetry, Differential Scanning; Drug Carriers; Drug Design; Electrochemistry; Magnetic Resonance Spectroscopy; Male; Microscopy, Electron, Scanning; Nanofibers; Ophthalmic Solutions; Polyvinyl Alcohol; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; Tears; Voriconazole; X-Ray Diffraction | 2016 |
Effect of Cumulative Intravenous Voriconazole Dose on Renal Function in Hematological Patients.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Female; Humans; Kidney; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Voriconazole; Young Adult | 2018 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
Continuous alternative to freeze drying: Manufacturing of cyclodextrin-based reconstitution powder from aqueous solution using scaled-up electrospinning.
Topics: Antifungal Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Crystallization; Excipients; Freeze Drying; Powders; Solubility; Technology, Pharmaceutical; Temperature; Voriconazole | 2019 |
Kolliphor® HS 15-cyclodextrin Complex for the Delivery of Voriconazole: Preparation, Characterization, and Antifungal Activity.
Topics: Animals; Antifungal Agents; Aspergillus niger; beta-Cyclodextrins; Candida albicans; Cryptococcosis; Cryptococcus neoformans; Drug Carriers; Drug Liberation; Female; Male; Mice; Microbial Sensitivity Tests; Polyethylene Glycols; Stearates; Surface-Active Agents; Voriconazole | 2020 |
Reply to letter to the Editor to 'Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin'.
Topics: beta-Cyclodextrins; Humans; Voriconazole | 2022 |
Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin.
Topics: beta-Cyclodextrins; Humans; Voriconazole | 2022 |
Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Mice; Mycoses; Solubility; Voriconazole | 2022 |